Characterization of the new AmpC β-lactamase FOX-8 reveals a single mutation, Phe313Leu, located in the R2 Loop that affects ceftazidime hydrolysis

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 10, 2013, Pages 5158-5161

  Pérez Llarena, Francisco José ^a   Kerff, Frédéric ^b   Zamorano, Laura ^c   Fernández, María Carmen ^a   Nuñez, Maria Luz ^d   Miró, Elisenda ^e   Oliver, Antonio ^c   Navarro, Ferran ^e   Bou, Germán ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPC BETA LACTAMASE FOX 8; AMPICILLIN; BETA LACTAMASE AMPC; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; IMIPENEM; LEUCINE; NITROCEFIN; PHENYLALANINE; UNCLASSIFIED DRUG;

ARTICLE; DRUG HYDROLYSIS; ENZYME STABILITY; ESCHERICHIA COLI; GENE MUTATION; GENETIC VARIABILITY; KINETICS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR BIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REDUCTION; SUBSTITUTION REACTION;

BACTERIAL PROTEINS; BETA-LACTAMASES; CEFTAZIDIME; ESCHERICHIA COLI; HYDROLYSIS; MUTATION;

EID: 84884245382     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00818-13     Document Type: Article

References (17)

1. Jacoby GA. 2009. AmpC-lactamases. Clin. Microbiol. Rev. 22:161-182.
2. Beceiro A, Bou G. 2004. Class C-lactamases: an increasing problem worldwide. Rev. Med. Microbiol. 15:141-152.
3. Pérez-Llarena FJ, Bou G. 2009. Beta-lactamase: the story so far. Curr. Med. Chem. 16:3740-3765.
4. Nordmann P, Mammeri H. 2007. Extended-spectrum cephalosporinases: structure, detection and epidemiology. Future Microbiol. 2:297-307.
5. Bauernfeind A, Wagner S, Jungwirth R, Schneider I, Meyer D. 1997. A novel classC-lactamase (FOX-2) in Escherichia coli conferring resistance to cephamycins. Antimicrob. Agents Chemother. 41:2041-2046.
6. Bou G, Oliver A, Ojeda M, Monzón C, Martínez-Beltrán J. 2000. Molecular characterization of FOX-4, a new AmpC-type plasmidmediated-lactamase from an Escherichia coli strain isolated in Spain. Antimicrob. Agents Chemother. 44:2549-2553.
7. Fosse T, Giraud-Morin C, Madinier I, Labia R. 2003. Sequence analysis and biochemical characterization of chromosomal CAV-1 (Aeromonas caviae), the parental cephalosporinase of plasmid-mediated AmpC "FOX" cluster. FEMS Microbiol. Lett. 222:93-98.
8. González Leiza M, Pérez-Diaz JC, Ayala J, Casellas JM, Martínez-Beltrán J, Bush K, Baquero F. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC plasmid-mediated beta-lactamase with two molecular variants. Antimicrob. Agents Chemother. 38:2150-2157.
9. Marchese A, Arlet G, Schito GC, Lagrange PH, Philippon A. 1998. Characterization of FOX-3, an AmpC-type plasmid-mediated-lactamase from an Italian isolate of Klebsiella oxytoca. Antimicrob. Agents Chemother. 42:464-467.
10. Queenan AM, Jenkins S, Bush K. 2001. Cloning and biochemical characterization of FOX-5, an AmpC plasmid-encoded-lactamase from a New York City Klebsiella pneumoniae clinical isolate. Antimicrob. Agents Chemother. 45:3189-3194.
11. Mallo S, Pérez-Llarena FJ, Kerff F, Soares NC, Galleni M, Bou G. 2010. A tripeptide deletion in the R2 loop of the class C beta-lactamase enzyme FOX-4 impairs cefoxitin hydrolysis and slightly increases susceptibility to beta-lactamase inhibitors. J. Antimicrob. Chemother. 65:1187-1194.
12. Pérez-Pérez FJ, Hanson ND. 2002. Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162.
13. García A, Navarro F, Miró E, Villa L, Mirelis B, Coll P, Carattoli A. 2007 Acquisition and diffusion of bla CTX-M-9 gene by R478-IncHI2 derivative plasmids. FEMS Microbiol. Lett. 271:71-77.
14. Liu SL, Hessel A, Sanderson KE. 1993. Genomic mapping with I-Ceu I, an intron-encoded endonuclease specific for genes for ribosomal RNA, in Salmonella spp., Escherichia coli, and other bacteria. Proc. Nat. Acad. Sci. U. S. A. 90:6874-6878.
15. Gutiérrez O, Juan C, Cercenado E, Navarro F, Bouza E, Col P, Pérez JL, Oliver A. 2007. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob. Agents Chemother. 51:4329-4335.
16. Miró E, Aguero J, Larrosa MN, Fernandez A, Conejo MC, Bou G, González-López JJ, Lara N, Martinez-Martinez L, Oliver A, Aracil B, Oteo J, Pascual A, Rodriguez-Baño J, Zamorano L, Navarro F. 2013. Prevalence and molecular epidemiology of acquired AmpC betalactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 32:253-259. (Erratum, 32:261-262.)
17. Kim JY, Jung HI, An YL, Lee JH, Kim SJ, Jeong SH, Lee KJ, Suh PG, Lee HS, Lee SH, Cha SS. 2006. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C beta-lactamase. Mol. Microbiol. 60:907-909.